Brief, valid measures of dyspnea and related functional limitations in chronic obstructive pulmonary disease (COPD)

Value in Health

Volumn 14, Issue 2, 2011, Pages 307-315

  Yount, Susan E ^a   Choi, Seung W ^a   Victorson, David ^a   Ruo, Bernice ^a   Cella, David ^a   Anton, Susan ^b   Hamilton, Alan ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^c BOEHRINGER INGELHEIM CANADA LTD   (Canada)

Author keywords

Chronic obstructive pulmonary disease; Computer adaptive testing; Dyspnea; Measurement

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; BASELINE DYSPNEA INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTERIZED ADAPTIVE TESTING; DISABILITY; DYSPNEA; EMOTIONAL STRESS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTERNAL CONSISTENCY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; PSYCHOMETRY; RATING SCALE; RESPIRATORY FUNCTION; SELF REPORT; SHORT FORM 36; SIMULATION; SYMPTOM; TEST RETEST RELIABILITY;

EID: 79959577834     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2010.11.009     Document Type: Article

References (39)

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. Respir Care 2002;47:1184-99.
2. Global Initiative for Chronic Obstructive Pulmonary Disease. Global Strategy for the Diagnosis, Management, and Prevention of COPD, Updated 2008. Available from: Www.goldcopd.com. [Accessed June 15, 2010].
3. National Heart, Lung and Blood Institute. Morbidity and Mortality: 2009 Chartbook on Cardiovascular, Lung and Blood Diseases. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health. Available from: Www.nhlbi.nih.gov/resources/ docs/2009-ChartBook.pdf. [Accessed June 15, 2010].
4. Ferrer M, Alonso J, Morera J, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. The quality of life of chronic obstructive pulmonary disease study group. Ann Intern Med 1997;127:1072-9. (Pubitemid 28012076)
5. Edelman NH, Kaplan RM, Buist AS, et al. Chronic obstructive pulmonary disease. Task Force on Research and Education for the Prevention and Control of Respiratory Diseases. Chest 1992;102(3 Suppl.):243S-56S.
6. Eisner MD, Blanc PD, Yelin EH, et al. COPD as a systemic disease: Impact on physical functional limitations. Am J Med 2008;121:789-96.
7. Petty TL. Benefits of and barriers to the widespread use of spirometry. Curr Opin Pulm Med 2005;11:115-20. (Pubitemid 40279917)
8. Eltayara L, Becklake MR, Volta CA, Milic-Emili, J. Relationship of chronic dyspnea and flow limitation in COPD patients. Am J Respir Crit Care Med 1996;154:1726-34.
9. Eakin EG, Sassi-Dambron DE, Ries AL, Kaplan RM. Reliability and validity of dyspnea measures in patients with obstructive lung disease. Int J Behav Med 1995;2:118-34.
10. Victorson DE, Anton S, Hamilton A, et al. A conceptual model of the experience of dyspnea and functional limitations in chronic obstructive pulmonary disease. Value Health 2009;12:1018-25.
11. Choi SW, Victorson DE, Yount S, et al. Development of a conceptual framework and calibrated item banks to measure patient reported dyspnea severity and related functional limitations. Value Health 2011;14:xx-xx.
12. Chang C-H, Reeve BB. Item Response Theory and its applications to patient-reported outcomes measurement. Eval Health Prof 2005;28:264-82. (Pubitemid 41129628)
13. Cella D, Chang CH. A discussion of Item Response Theory (IRT) and its applications in health status assessment. Med Care 2000;38(9 Suppl.):1166-72.
14. Stansfeld SA, Roberts R, Foot SP. Assessing the validity of the SF-36 General Health Survey. Qual Life Res 1997;6:217-24. (Pubitemid 27293868)
15. Lord FM, Novick MR. Statistical Theories of Mental Test Scores. Reading, MA: Addison-Wesley, 1968.
16. Bjorner JB, Chang CH, Thissen D, Reeve BB. Developing tailored instruments: Item banking and computerized adaptive assessment. Qual Life Res 2007;16(Suppl. 1):95-108. (Pubitemid 47036912)
17. Cella D, Gershon R, Lai J-S, Choi SW. The future of outcomes measurement: Item banking, tailored short-forms, and computerized adaptive assessment. Qual Life Res 2007;16: 133-41. (Pubitemid 47036925)
18. Choi SW, Swartz RJ. Comparison of CAT item selection criteria for polytomous items. Appl Psychol Meas 2009;33: 419-40.
19. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea: Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984;85:751-8. (Pubitemid 14121920)
20. Mahler DA, Ward J, Fierro-Carrion G, et al. Development of self-administered versions of modified baseline and transition dyspnea indexes in COPD. COPD 2004;1:1-8.
21. Medical Research Council Committee. Standardised questionnaire on respiratory symptoms: A statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). BMJ 1960;2:1665.
22. Ware JE Jr, Sherbourne CD. The MOS 36 Item Short Form Health Survey (SF 36). 1. Conceptual framework and item selection. Med Care 1992;30:473-83.
23. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70. (Pubitemid 13098606)
24. Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987;42:773-8. (Pubitemid 17142007)
25. Schunemann HR, Goldstein R, Mador MJ, et al. A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire. Eur Respir J 2005;25:31-40. (Pubitemid 40207728)
26. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;10:37-46.
27. Choi SW. Firestar: Computerized adaptive testing simulation program for polytomous IRT models. Appl Psychol Meas 2009;33:644-5.
28. US Food And Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Guidance for industry. Patient-Reported Outcome measures: Use in medical product development to support labeling claims. Available from: Www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ UCM193282.pdf. [Accessed December 2009].
29. Ferris BG. Recommended respiratory disease questionnaires for use with adults and children in epidemiological research. Am Rev Respir Dis 1978;118(Suppl.):S1-53.
30. Stoller JK, Ferranti R, Feinstein AR. Further specification and evaluation of a new clinical index for dyspnea. Am Rev Respir Dis 1986;34:1129-34. (Pubitemid 17216885)
31. McGavin CR, Artvinli M, McHardy GJR. Dyspnoea, disability and distance walked: Comparison of estimates of exercise performance in respiratory disease. BMJ 1978;2:241-3. (Pubitemid 8382018)
32. Eakin EG, Resnikoff PM, Prewitt LM, et al. Validation of the USCD Shortness of Breath Questionnaire [abstract]. J Cardiopulm Rehab 1994;14:322.
33. Hyland ME, Bott J, Singh S, Kenyon CAP. Domains, constructs, and the development of the breathing problems questionnaire. Qual Life Res 1994;3:245-6.
34. Borg G. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377-81. (Pubitemid 13215050)
35. Jones PW, Quirk FH, Baveystock CM. The St. George's Respiratory Questionnaire. Respir Med 1991;85:25-31.
36. Mahler DA. Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3,234-8. (Pubitemid 43668187)
37. Fletcher CM, Elmes PC, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in the working population. BMJ 1959;2:257.
38. Aitken RB. A growing edge of measurement of feelings. Proc R Soc Med 1969;62:989-93.
39. Quirk FH, Jones PW. Repeatability of two new short airways questionnaires. Thorax 1994;49:1075-9.